AgenciesThe public issue will consist of fresh issue of equity shares of up to Rs. 3000 crore and offer for sale (OFS) of up to 8,938,870 equity shares to the promoter Snehal Ravjibhai Patel.
.
The face value of equity share is Rs.10 each.
SPC said it proposes to utilize the net proceeds of the fresh issue towards repayment of debt to the tune of Rs 55 crore, funding capex that includes investing Rs 122 crore for setting up phase -2 unit at Dahej to expand product offerings and Rs 40 crore earmarked towards working capital requirements and the rest for general corporate purposes.
SPC has a USFDA approved facility for 6-Chloro-Hexane-2-One that's used in manufacture of cardiovascular drug pentoxifylline.
The company develops pharma intermediates and works with pharmaceutical companies who seek USFDA compliant manufacturing facilities as a part of their supply chain.
Ambit and HDFC Bank are the Book Running Lead Managers to the IPO issue.
Wednesday, 29 Mar, 2023- Front Page
- Pure Politics
- ET Markets
- Smart Investing
- More
‘Pledge-Repledge’ Model Mooted for Brokers, InvestorsThe capital market authorities are understood to be examining a ‘pledge-repledge mechanism’ to meet the twin objectives of ring-fencing unused investor money lying with the stock brokers while simultaneously letting them earn from the float.
Women Athletes Score Record Brand DealsAs an increasing number of Indian women excel in cricket, boxing, badminton, hockey and other sports, the number of deals and the endorsement fees they’re getting have hit an all-time high, executives said.
ITC Plans ₹3kcr Yearly Growth PushITC Ltd chairman and managing director Sanjiv Puri said the company will accelerate investments, which had slowed during the pandemic, with a corpus of around ₹3,000 crore annually for the next few years, primarily for building manufacturing capacities and accelerating growth.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Get Unlimited Access to The Economic Times 
